Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Return on invested capitalprofit made on each $100 put into the business | -21.0% |
| Return on equityprofit vs. shareholders' accounting value | -23.6% |
| Change in share countnegative = the company is buying back its shares | +243.0% |
1 insider sold $24K on the open market.
| Azoulay SalomonChief Medical Officer | SoldAug 4 | 370 shat $65.77 · $24K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy